Latest News & Updates
Breaking News
1 hour ago
Vaibhavi M.
Other trending news you may like to read
Valneva Withdraws U.S. Regulatory Filings For IXCHIQ Chikungunya Vaccine, Halts U.S. Development Following FDA Safety Review
Valneva pulls U.S. regulatory filings for IXCHIQ after FDA actions, while continuing post-marketing activities outside the U.S.
Vaibhavi M.
Ocugen Reports Positive Phase 2 Interim Data; OCU410 Gene Therapy Shows Reduced Lesion Growth And Favourable Safety In dAMD
Ocugen shares positive interim Phase 2 results for OCU410, demonstrating meaningful reduction in lesion growth in geographic atrophy patients.
Vaibhavi M.
GT Biopharma Submits IND To FDA For GTB-5550 TriKE, A B7-H3-Targeted NK Cell Engager For Treating B7-H3–Expressing Solid Tumor Cancers
GT Biopharma submits an FDA IND for GTB-5550, a B7-H3–targeted TriKE NK cell engager planned for Phase 1 solid tumor studies.
Simantini Singh Deo
Hikma Achieves B Scores For Climate Change And Water Security In Carbon Disclosure Project 2025; Strengthens Environmental Performance
Hikma earns B scores in CDP 2025 for Climate Change and Water Security, reflecting improved environmental performance.
Vaibhavi M.
